Lynx.MD’s Post

We're celebrating another win! BioStrand (a subsidiary of IPA), also won the Best Demo award for the most creative use of AI technology at the InterSystems Global Summit in June! We proudly took home the prestigious Impact Award as well. Thank you to InterSystems for an invitation to the event. LENSᵃⁱ™ Integrated Intelligence Technology Vector Search capabilities, with InterSystems inside, recently launched. LENSᵃⁱ’s foundational AI model powered by HYFT® technology is revolutionizing drug discovery by leveraging vector search to map complex relationships between data points. This innovative approach identifies similarities and patterns across vast biological datasets, uncovering potential drug candidates faster and more efficiently. By uniting text, sequence, structure, and function into a single platform, LENSᵃⁱ streamlines the drug discovery and development process, making data useful in unprecedented ways. Want to see what it can do for you? Contact us for a live demo: https://bit.ly/46e9SNb InterSystems #VectorSearch #DrugDiscovery #mAb #Antibodies #TechBio #Biotech

Join the #LSOS24 session, “Pioneering Health Solutions: Unlocking the Power of Biotech and HealthTech,” to discover how Collaborative Drug Discovery - CDD Vault accelerates the transformation of groundbreaking research ideas into innovative discoveries. #LifeScience #Technology #DeepLearning #Data

🤩 The moment you've all been waiting for is here! Registrations are now OPEN for Science for health: Biology meets Technology 👉 Register https://lnkd.in/eW8p5Av4 If you attend only one conference this autumn, let it be Science for Health: Biology Meets Technology. This year’s edition is focused on #AI, #Data & #Digitalisation. 𝗔 𝘀𝗻𝗲𝗮𝗸 𝗽𝗲𝗲𝗸 𝗮𝘁 𝘀𝗼𝗺𝗲 𝘁𝗼𝗽𝗶𝗰𝘀 𝗼𝗻 𝘁𝗵𝗲 𝗽𝗿𝗼𝗴𝗿𝗮𝗺: - Hacking the Brain: Treating Disorders with Your #DigitalTwin - Breakthrough AI-driven #DrugDiscovery - Debate: The use of #healthdata for research - framework and challenges - AI: Hindsight, insight, foresight 🔥 Members of MEDVIA and BioWin - The Health Cluster of Wallonia get a 60% discount on the fee #SFH2024 is made possible through a collaboration with HST Group - Health, Science and Technology Group, J&J Innovative Medicine Belgium, Pfizer, UCB, GSK #healthinnovation #healthtech #medtech #biotech #digitalhealth

[𝐖𝐞𝐛𝐢𝐧𝐚𝐫 𝐒𝐩𝐞𝐚𝐤𝐞𝐫 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧] 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐰𝐢𝐭𝐡 𝐆𝐞𝐧𝐨𝐦𝐢𝐜 𝐃𝐚𝐭𝐚 𝐚𝐧𝐝 𝐀𝐈 Join us for an insightful webinar designed to explore the transformative power of genomic data and AI in digital health on August 29 (Thursday) 2024. Discover the latest advancements, future opportunities, and practical applications of these cutting-edge innovations that are set to revolutionize healthcare. Don't miss this opportunity to learn from Eric Doherty, MBA, Former Visionary President PERSOWN, regarding "Driving Drug Development with Genomic Data: Precision Drug Development" and "Integrating Genomic Data with Mobile/Wearable Devices for Holistic Health Monitoring." Register today to secure your spot and be part of this transformative discussion: https://lnkd.in/dyg3XgCR #DigitalHealth,  #Pharmacogenomics,  #AIinHealthcare,  #GeneticSequencing,  #Genomics,  #Telemedicine,  #HealthTech,  #PrecisionMedicine,  #BigDataHealth,  #HealthcareInnovation,  #PersonalizedMedicine

Due to the large number of significant company news events that occur each week, we have decided to publish weekly (although we initially planned for a bi-weekly format). However, we will select the most interesting and important news that impacts the life of the company and its partners. 1. The United States Patent and Trademark Office has issued us an official notice for a patent that includes a unique and importantly, very comprehensive set of algorithms, securing our company the rights to use advanced AI models. 2. Due to our expressed development focus towards generative AI, RAG, and VS technologies, our company will now officially be known as #PGxAI with main domains being pgx.ai and pgxai.com. Meanwhile, all PGxCare projects that involve the use of traditional pharmacogenetics algorithms without analyzing other omics markers and assessing clinical outcomes will remain under the division dealing with routine implementation. 3. We have been invited to participate in the largest annual InterSystems Global Summit (June 9-12, 2024 - National Harbor, Maryland https://lnkd.in/e4cMjbHJ) where we will also present at Demos and Drinks. We will showcase our technology and compete for the award for best use case of Vector Search. Our global central AI model, which analyzes hundreds of thousands of clinical outcomes daily along with thousands of omics markers, is undoubtedly a great case, but we need your support, so come and cheer for us (Mon, June 10). See you at the Summit! #pgxcare #pharamcogenetics #precisionmedicine #pharmacogenomics #intersystems #omics #artificialintelligence #ai #genai #vectorsearch #healthcare #healthtech #biotech #startup

As part of our #XscaleInsights series, Anjani Bansal from Global Brain Corporation delivered a thought-provoking insight during Coffee with Xscale 2.0: "The future of healthcare lies in AI, especially in personal medicine and drug discovery." Anjani shared how AI has the power to dramatically transform drug development, cutting the timeline for new drugs—from the current 10 years for clinical trials—to a fraction of that. Imagine the impact: faster treatments, personalized medicine, and a revolution in healthcare innovation. The opportunities are limitless as AI reshapes the way we discover life-saving drugs. Catch more groundbreaking insights from this conversation on YouTube! #XscaleInsights #HealthcareRevolution #AIinMedicine ##GlobalBrain #InnovationInHealthcare #CoffeeWithXscale Neeraj Saxena Anshul Saxena Amit Sharma Addison Appu Rajat Tandon

Last month we hosted a Foundational Models webinar and the No. 1 request was to help better understand which models are best fit for which use cases. You ask and we deliver. Save your spot for “Mapping foundational models to use cases in biotech and pharma” webinar presented by our in-house AI experts, Daniel Koster and Dror Hilman. What we will cover: 🔹 Most promising foundational models for biotech and pharma today 🔹 How to categorize these models into various biologically compelling categories 🔹 Data and compute requirements for each application More details below 👇 #bioinformatics #dataanalytics #biotech

SRM Tech is proud to present BIOeRA™️, our innovative AI framework designed exclusively for the Life Sciences and Healthcare sectors.   Watch this video to learn more and unlock the benefits of BIOeRA for your business!   Reach out to us at hls@srmtech.com or comment below to connect. 👇   #SRMTech #BIOeRA #GenAI

Stop by at #MNRainmaker Booth#2 to learn more about SRM BIOeRA for Healthcare and life sciences. #MNRainmaker24 #RevenueOptimization #RevenueManagement #SRMTechnologies #SRMTech #BIOeRA #GenAI

Tech update! Tune in to Jennifer Bath, Ph.D. and Radius Research discussing the innovative LENSᵃⁱ™ Integrated Intelligence Platform API by BioStrand (IPA subsidiary). This game-changing API plugs directly into large pharma or biotech existing platforms, transforming their ability to harmonize data and unlock deep insights. A huge step forward for IPA in commercialization and development timelines, enabling direct access to LENSᵃⁱ for researchers in drug discovery. We are particularly focused on optimizing electronic health record (EHR) data to provide deep insights into precision medicine. Watch the full interview: https://bit.ly/4ezlMp1 #LENSai #BiotechAPI #PrecisionMedicine #Ai #LLM #EHR #Innovation #TechBio #RadiusResearch Radius Research - Investments BioStrand (a subsidiary of IPA)